Biomoneta provides active air‑decontamination solutions using its ZeBox technology, which silently captures and destroys over 99.999% of airborne microorganisms—including drug‑resistant bacteria, viruses and fungi—at the source. Its product lines, Avata Rx (US‑FDA Class II medical device) and Avata (consumer‑grade), deliver continuous, clinically validated sterility for hospitals, labs, pharma cleanrooms, elder‑care facilities and homes.
Funding
Funding not disclosed
Founders
Product
Problem
Hospital‑acquired infections (HAIs) and other airborne disease transmissions arise because conventional air handling relies on passive filtration, which only traps microbes without eliminating them. This leaves patients, staff, and occupants exposed to multidrug‑resistant bacteria, viruses and fungi, especially in high‑risk settings such as ICUs, operating rooms and laboratories.
Solution
Biomoneta addresses this gap with ZeBox, an active air‑decontamination technology that continuously captures and destroys >99.999% of airborne microorganisms, including drug‑resistant bacteria, viruses (e.g., SARS‑CoV‑2) and fungal spores. The system operates silently in the presence of people, using electrostatic capture and rapid microbe electrocution without generating ozone, UV radiation or harmful by‑products. ZeBox is integrated into two product lines: Avata Rx, a US‑FDA Class II‑cleared medical‑grade device for hospitals, IVF labs and other clinical environments, and Avata, a consumer‑grade unit for homes, elder‑care and recovery settings. Both units provide real‑time air‑quality monitoring, cover areas up to 650 sq ft (Rx) or 250 sq ft (consumer), and require minimal maintenance, delivering continuous, clinically validated sterility at the source of infection.
Target Audience
Primary customers are healthcare facilities (hospitals, ICUs, operating theatres, labs, IVF centers), pharmaceutical and biotech cleanrooms, and corporate or residential users seeking medical‑grade air safety, such as elder‑care facilities and home recovery environments.
Features
- Proprietary ZeBox technology that electrostatically captures microbes and destroys them on contact with >99.999% efficacy
- Certified US‑FDA Class II medical device (Avata Rx) and ISO 13485‑compliant manufacturing
- Silent, continuous operation with zero downtime and no ozone, UV or harmful radiation
- Real‑time air‑quality indicator and centralized monitoring dashboard
- Broad spectrum removal of particulate matter, VOCs, bacteria, viruses, fungi and spores
- Scalable form factors: wall‑mounted or tabletop units covering up to 650 sq ft (clinical) or 250 sq ft (home)
- Validated by peer‑reviewed studies (Nature, Journal of Hospital Infection) and multiple international patents